In Vitro Antimicrobial Susceptibility to Isepamicin of 6,296 Enterobacteriaceae Clinical Isolates Collected at a Tertiary Care University Hospital in Greece

Antimicrobial Agents and Chemotherapy, 05/17/2012

Isepamicin exhibited high in vitro activity against almost all of the Enterobacteriaceae species. It could particularly serve as a last–resort therapeutic option for carbapenem–resistant K. pneumoniae in the region, where it is endemic, as it does not show considerable cross–resistance with other aminoglycosides.

Print Article Summary Cat 2 CME Report